589 related articles for article (PubMed ID: 23395974)
1. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice.
Kyaw T; Winship A; Tay C; Kanellakis P; Hosseini H; Cao A; Li P; Tipping P; Bobik A; Toh BH
Circulation; 2013 Mar; 127(9):1028-39. PubMed ID: 23395974
[TBL] [Abstract][Full Text] [Related]
2. CD4+ natural killer T cells potently augment aortic root atherosclerosis by perforin- and granzyme B-dependent cytotoxicity.
Li Y; To K; Kanellakis P; Hosseini H; Deswaerte V; Tipping P; Smyth MJ; Toh BH; Bobik A; Kyaw T
Circ Res; 2015 Jan; 116(2):245-54. PubMed ID: 25398236
[TBL] [Abstract][Full Text] [Related]
3. CD8+ T Cells Regulate Monopoiesis and Circulating Ly6C-high Monocyte Levels in Atherosclerosis in Mice.
Cochain C; Koch M; Chaudhari SM; Busch M; Pelisek J; Boon L; Zernecke A
Circ Res; 2015 Jul; 117(3):244-53. PubMed ID: 25991812
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
[TBL] [Abstract][Full Text] [Related]
5. CD8(+)CD25(+) T cells reduce atherosclerosis in apoE(-/-) mice.
Zhou J; Dimayuga PC; Zhao X; Yano J; Lio WM; Trinidad P; Honjo T; Cercek B; Shah PK; Chyu KY
Biochem Biophys Res Commun; 2014 Jan; 443(3):864-70. PubMed ID: 24342615
[TBL] [Abstract][Full Text] [Related]
6. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
[TBL] [Abstract][Full Text] [Related]
7. CD137-inducing factors from T cells and macrophages accelerate the destabilization of atherosclerotic plaques in hyperlipidemic mice.
Jung IH; Choi JH; Jin J; Jeong SJ; Jeon S; Lim C; Lee MR; Yoo JY; Sonn SK; Kim YH; Choi BK; Kwon BS; Seoh JY; Lee CW; Kim DY; Oh GT
FASEB J; 2014 Nov; 28(11):4779-91. PubMed ID: 25059229
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
Cipriani S; Francisci D; Mencarelli A; Renga B; Schiaroli E; D'Amore C; Baldelli F; Fiorucci S
Circulation; 2013 May; 127(21):2114-24. PubMed ID: 23633271
[TBL] [Abstract][Full Text] [Related]
9. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms.
Selathurai A; Deswaerte V; Kanellakis P; Tipping P; Toh BH; Bobik A; Kyaw T
Cardiovasc Res; 2014 Apr; 102(1):128-37. PubMed ID: 24469537
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
Erbel C; Chen L; Bea F; Wangler S; Celik S; Lasitschka F; Wang Y; Böckler D; Katus HA; Dengler TJ
J Immunol; 2009 Dec; 183(12):8167-75. PubMed ID: 20007582
[TBL] [Abstract][Full Text] [Related]
12. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.
Kyaw T; Tay C; Krishnamurthi S; Kanellakis P; Agrotis A; Tipping P; Bobik A; Toh BH
Circ Res; 2011 Sep; 109(8):830-40. PubMed ID: 21868694
[TBL] [Abstract][Full Text] [Related]
13. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.
Davenport P; Tipping PG
Am J Pathol; 2003 Sep; 163(3):1117-25. PubMed ID: 12937153
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death.
Seijkens TTP; Poels K; Meiler S; van Tiel CM; Kusters PJH; Reiche M; Atzler D; Winkels H; Tjwa M; Poelman H; Slütter B; Kuiper J; Gijbels M; Kuivenhoven JA; Matic LP; Paulsson-Berne G; Hedin U; Hansson GK; Nicolaes GAF; Daemen MJAP; Weber C; Gerdes N; de Winther MPJ; Lutgens E
Eur Heart J; 2019 Jan; 40(4):372-382. PubMed ID: 30452556
[TBL] [Abstract][Full Text] [Related]
15. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
[TBL] [Abstract][Full Text] [Related]
16. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.
Pejnovic N; Vratimos A; Lee SH; Popadic D; Takeda K; Akira S; Chan WL
Mol Immunol; 2009 Nov; 47(1):37-45. PubMed ID: 19201478
[TBL] [Abstract][Full Text] [Related]
17. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
[TBL] [Abstract][Full Text] [Related]
18. Ets2 determines the inflammatory state of endothelial cells in advanced atherosclerotic lesions.
Cheng C; Tempel D; Den Dekker WK; Haasdijk R; Chrifi I; Bos FL; Wagtmans K; van de Kamp EH; Blonden L; Biessen EA; Moll F; Pasterkamp G; Serruys PW; Schulte-Merker S; Duckers HJ
Circ Res; 2011 Aug; 109(4):382-95. PubMed ID: 21700929
[TBL] [Abstract][Full Text] [Related]
19. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
[TBL] [Abstract][Full Text] [Related]
20. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
